147 related articles for article (PubMed ID: 38695944)
1. Primary lung cancer in children and adolescents.
Chen Q; Cheng J; Wang L; Lv X; Hu J
J Cancer Res Clin Oncol; 2024 May; 150(5):225. PubMed ID: 38695944
[TBL] [Abstract][Full Text] [Related]
2. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
3. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.
Qu R; Tu D; Cai Y; Ping W; Fu X
Front Oncol; 2022; 12():979522. PubMed ID: 36185186
[TBL] [Abstract][Full Text] [Related]
5. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
7. Ground glass opacity featured lung adenocarcinoma in teenagers.
Wu H; Zhang Y; Hu H; Li Y; Shen X; Liu Q; Wang S; Chen H
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3719-3724. PubMed ID: 33829316
[TBL] [Abstract][Full Text] [Related]
8. Ten-Year Follow-up Results of Pure Ground-Glass Opacity-Featured Lung Adenocarcinomas After Surgery.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
Ann Thorac Surg; 2023 Aug; 116(2):230-237. PubMed ID: 36646243
[TBL] [Abstract][Full Text] [Related]
9. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
[TBL] [Abstract][Full Text] [Related]
10. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
[TBL] [Abstract][Full Text] [Related]
11. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
12. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
13. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
[TBL] [Abstract][Full Text] [Related]
14. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y
Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995
[TBL] [Abstract][Full Text] [Related]
15. Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers.
Chen PH; Chang KM; Tseng WC; Chen CH; Chao JI
Thorac Cancer; 2019 Nov; 10(11):2133-2141. PubMed ID: 31571421
[TBL] [Abstract][Full Text] [Related]
16. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
Lee HY; Lee KS
J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
[TBL] [Abstract][Full Text] [Related]
17. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
[TBL] [Abstract][Full Text] [Related]
18. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
19. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
20. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT.
Park S; Lee SM; Choe J; Choi S; Do KH; Seo JB
Radiology; 2023 May; 307(3):e222422. PubMed ID: 36943079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
